Clicky

Zealand Pharma A/S(ZEAL) News

Date Title
Jun 6 Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Jun 2 Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome
May 19 Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer
Feb 21 Zealand Pharma AS (ZLDPF) Q4 2024 Earnings Call Highlights: Strong Cash Position and Obesity ...
Feb 20 Zealand Pharma steadfastly upholds amylin-based obesity drug strategy
Feb 20 Zealand Pharma convenes its Annual General Meeting 2025
Feb 20 Correction: Zealand Pharma Announces Financial Results for the Full Year 2024
Feb 20 Zealand Pharma Announces Financial Results for the Full Year 2024
Oct 13 GLP-1 Stocks Aren't the Only Way to Benefit From the Weight Loss Drugs Boom
Oct 11 Next-gen weight loss drugs will have fewer side effects than Ozempic, pharma CEO says
Oct 9 FDA declines to approve Zealand Pharma’s hypoglycaemia therapy in infants
Jul 30 Better Weight Loss Drug Stock: Viking Therapeutics vs. Zealand Pharma
Jul 29 Zealand Pharma Appoints Eric Cox as Chief Commercial Officer
Jun 25 Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary shares raising gross proceeds of USD 1 billion / DKK 7 billion
Jun 25 Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billion
Jun 25 Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billion
Jun 24 Strength Seen in Zealand Pharma AS (ZLDPF): Can Its 11.6% Jump Turn into More Strength?
Jun 21 Existing home sales, a day with Fed's Susan Collins: Catalysts
Jun 21 Zealand Pharma's Weight Loss Drug Performs Well in Early Trials
Jun 21 Zealand Pharma surges on weight-loss drug trial results